S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The 3-Stock Retirement Blueprint (Ad)
EV Battery Maker Freyr Set For Major Global Expansion
Russia accused of 'kidnapping' head of Ukraine nuclear plant
The 3-Stock Retirement Blueprint (Ad)
How major US stock indexes fared Friday 9/30/2022
Putin accuses the West of sabotaging Baltic Sea pipelines
The 3-Stock Retirement Blueprint (Ad)
West rejects Putin's claim it sabotaged Baltic gas pipelines
NATO chief rejects Russia’s “illegal and illegitimate” annexation of 4 parts of Ukraine
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The 3-Stock Retirement Blueprint (Ad)
EV Battery Maker Freyr Set For Major Global Expansion
Russia accused of 'kidnapping' head of Ukraine nuclear plant
The 3-Stock Retirement Blueprint (Ad)
How major US stock indexes fared Friday 9/30/2022
Putin accuses the West of sabotaging Baltic Sea pipelines
The 3-Stock Retirement Blueprint (Ad)
West rejects Putin's claim it sabotaged Baltic gas pipelines
NATO chief rejects Russia’s “illegal and illegitimate” annexation of 4 parts of Ukraine
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The 3-Stock Retirement Blueprint (Ad)
EV Battery Maker Freyr Set For Major Global Expansion
Russia accused of 'kidnapping' head of Ukraine nuclear plant
The 3-Stock Retirement Blueprint (Ad)
How major US stock indexes fared Friday 9/30/2022
Putin accuses the West of sabotaging Baltic Sea pipelines
The 3-Stock Retirement Blueprint (Ad)
West rejects Putin's claim it sabotaged Baltic gas pipelines
NATO chief rejects Russia’s “illegal and illegitimate” annexation of 4 parts of Ukraine
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The 3-Stock Retirement Blueprint (Ad)
EV Battery Maker Freyr Set For Major Global Expansion
Russia accused of 'kidnapping' head of Ukraine nuclear plant
The 3-Stock Retirement Blueprint (Ad)
How major US stock indexes fared Friday 9/30/2022
Putin accuses the West of sabotaging Baltic Sea pipelines
The 3-Stock Retirement Blueprint (Ad)
West rejects Putin's claim it sabotaged Baltic gas pipelines
NATO chief rejects Russia’s “illegal and illegitimate” annexation of 4 parts of Ukraine
NASDAQ:AVGR

Avinger - AVGR Stock Forecast, Price & News

$1.15
-0.07 (-5.74%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.13
$1.22
50-Day Range
$1.15
$1.84
52-Week Range
$1.13
$19.26
Volume
16,545 shs
Average Volume
40,665 shs
Market Capitalization
$8.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.50

Avinger MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
2,030.4% Upside
$24.50 Price Target
Short Interest
Healthy
1.81% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.67mentions of Avinger in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

AVGR stock logo

About Avinger (NASDAQ:AVGR) Stock

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Stock News Headlines

Analyzing Nephros (NASDAQ:NEPH) and Avinger (NASDAQ:AVGR)
Avinger, Inc. (AVGR)
Avinger Reports Second Quarter 2022 Results
Avinger stock slides on ~$5M securities offering
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Company Calendar

Last Earnings
8/11/2022
Today
10/01/2022
Next Earnings (Estimated)
11/10/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVGR
Employees
68
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$24.50
High Stock Price Forecast
$40.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+2,030.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-17,410,000.00
Net Margins
-219.16%
Pretax Margin
-219.16%

Debt

Sales & Book Value

Annual Sales
$10.13 million
Book Value
$2.03 per share

Miscellaneous

Free Float
7,006,000
Market Cap
$8.10 million
Optionable
Not Optionable
Beta
1.62

Key Executives

  • Mr. Jeffrey M. Soinski (Age 60)
    Pres, CEO & Director
    Comp: $594.82k
  • Mr. Himanshu N. Patel (Age 62)
    Chief Technology Officer
    Comp: $416.05k
  • Mr. Nabeel Subainati (Age 39)
    VP, Controller, Principal Financial Officer & Accounting Officer
  • Mr. Keith Schaefer
    Chief Operating Officer













AVGR Stock - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

What is Avinger's stock price forecast for 2022?

2 brokerages have issued 1-year price targets for Avinger's stock. Their AVGR share price forecasts range from $9.00 to $40.00. On average, they expect the company's share price to reach $24.50 in the next year. This suggests a possible upside of 2,030.4% from the stock's current price.
View analysts price targets for AVGR
or view top-rated stocks among Wall Street analysts.

How have AVGR shares performed in 2022?

Avinger's stock was trading at $9.00 on January 1st, 2022. Since then, AVGR shares have decreased by 87.2% and is now trading at $1.15.
View the best growth stocks for 2022 here
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 10th 2022.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) announced its quarterly earnings results on Thursday, August, 11th. The medical device company reported ($0.94) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.09) by $0.15. The medical device company had revenue of $2.13 million for the quarter, compared to analysts' expectations of $2.38 million. Avinger had a negative trailing twelve-month return on equity of 209.14% and a negative net margin of 219.16%. During the same period last year, the firm posted ($0.80) EPS.

When did Avinger's stock split?

Avinger's stock reverse split on the morning of Tuesday, March 15th 2022. The 1-20 reverse split was announced on Tuesday, March 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $1.15.

How much money does Avinger make?

Avinger (NASDAQ:AVGR) has a market capitalization of $8.10 million and generates $10.13 million in revenue each year. The medical device company earns $-17,410,000.00 in net income (profit) each year or ($5.73) on an earnings per share basis.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The official website for the company is www.avinger.com. The medical device company can be reached via phone at (650) 241-7900, via email at info@dawson3d.com, or via fax at 800-229-2696.

This page (NASDAQ:AVGR) was last updated on 10/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.